How Avisalegis Can Make It Easier to Follow ANVISA Regulations

How Avisalegis Can Make It Easier to Follow ANVISA Regulations

Avisalegis ANVISA: Tool for regulatory monitoring of medical devices.

What is Avisalegis and How Does It Impact the Healthcare Industry?

The National Health Surveillance Agency (ANVISA) recently launched Avisalegis, an innovative service that allows you to receive alerts about new regulatory publications. With this tool, medical device manufacturers, pharmaceutical companies, and other regulated industries can quickly keep up with any updates that impact their compliance processes.

Avisalegis allows interested parties to select specific types of normative acts, such as Public Consultations and Resolutions of the Collegiate Board (RDC), in addition to macro topics of interest, such as Medicines and Medical Devices. Thus, each user can customize notifications according to their strategic needs.

Benefits of Avisalegis for Companies in the Regulated Sector

Efficient monitoring of ANVISA regulations is essential to ensure legal certainty and quick adaptation to regulatory requirements. Avisalegis brings several advantages to companies in the health sector, such as:

  • Anticipate regulatory changes: Ensuring time for necessary adjustments.
  • Reduce risks of non-compliance: Tracking publications in an automatic and structured way.
  • Optimize internal processes: Facilitating the work of regulatory and compliance teams.

With the implementation of this service, companies gain greater predictability and security in regulatory monitoring.

How QR Group Assists with Regulatory Monitoring

At QR Group, we know that compliance with regulatory requirements is a critical factor for the entry and permanence of products in the Brazilian market. Therefore, we offer specialized support for manufacturers and distributors of health products, ensuring that they are always in compliance with ANVISA.

Our team of experts continuously analyzes regulatory updates and assists companies in the agile implementation of new guidelines. With the use of tools such as Avisalegis and our personalized regulatory consulting, we ensure a more efficient and secure process for our clients.

Do you want to keep your company always up to date?

QR Group is ready to assist your company in adapting to ANVISA regulations in a strategic and safe way. Contact us and find out how we can optimize your regulatory process in Brazil.

 

Source: ANVISA